Delivery Order SPE2DB20D1100-SPE2DB22FD4Q4

<p>The Defense Logistics Agency (DOD) awarded a $262,342.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division to provide 4558639319 OCREVUS 300 MG/10 ML VIAL 10ML pharmaceutical products. The place of performance will be in Conshohocken, Pennsylvania and the period of performance is from September 29, 2022 through October 21, 2022. No applicable subcontractors were identified.</p>

<p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded a $437,238.00 delivery order contract to Amerisourcebergen Drug Corporation Corporate Office Division to provide 4558105410 OCREVUS 300 MG/10 ML VIAL 10ML pharmaceutical products. The contract has a place of performance in Conshohocken, Pennsylvania and runs from August 15, 2022 through September 6, 2022. The pricing for this firm fixed price contract was set at award. No subcontractors were identified.</p>

<p>The Defense Logistics Agency Troop Support Medical awarded a $273,273.75 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division to provide 4557971733 OCREVUS 300 MG/10 ML VIAL 10ML pharmaceutical products. The place of performance is Conshohocken, Pennsylvania and the period of performance is from August 2, 2022 through August 23, 2022. No applicable subcontractors were identified.</p>

The Defense Logistics Agency issued a $62,536.68 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for Ocrevus 300 mg/10 mL vials under a firm fixed-price arrangement. The order's ultimate completion date is March 30, 2026. Place of performance is Conshohocken, Pennsylvania. The delivery order was issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, which supports pharmaceutical supply across military healthcare systems globally. Amerisourcebergen...

<p>The Defense Logistics Agency awarded a $90,474.88 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for Ocrevus 300 MG/10 ML vials. The contract has a place of performance in Conshohocken, Pennsylvania and a completion date of November 2, 2023. No set-aside designation was used for this award to procure the multiple sclerosis treatment drug.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 26, 2026, for Ocrevus 300 mg/10 mL vials with a ceiling value of $76,913.10.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 19, 2026, and is priced on a firm fixed-price basis.</p>

The Defense Logistics Agency awarded a firm fixed price delivery order valued at $45,237.44 to Amerisourcebergen Drug Corporation for the supply of 4562055207 Ocrevus 300 MG/10 ML Vials. Amerisourcebergen will deliver 10ML vials of the multiple sclerosis treatment Ocrevus to a location in Conshohocken, Pennsylvania under a start date of September 5, 2023 concluding on September 26, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. The...

<p>The Defense Logistics Agency issued a $25,637.70 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for Ocrevus 300 mg/10 ml vials.</p> <p>Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure and an ultimate completion date of May 18, 2026. No set-aside applied to this issuance.</p>

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 mg/10 ml vials. The total potential value of the award is $128,918.52, with a completion date of October 15, 2021. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and...

The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 300 mg/10 ml vials of the pharmaceutical product OCREVUS. The $107,432.10 contract has a completion date of December 8, 2021 and was awarded on November 16, 2021. Amerisourcebergen Drug Corp has provided a range of pharmaceutical products and medical supplies to support Defense Logistics Agency programs. This...